Omalizumab and the risk of malignancy: Results from a pooled analysis William Busse, MDa, , , Roland Buhl, MA, PhDb, Carlos Fernandez Vidaurre, MD, MPHc, Martin Blogg, BSc (Hons), CStatd, Jin Zhu, PhDe, Mark D. Eisner, MD, MPHe, Janice Canvin, MD, FRCPCd a Department of Medicine, University of Wisco...